Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06834594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

Study acronym: BOOST
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 30, 2026 → Jul 30, 2028
See other at-risk trials from Children's Mercy Hospital Kansas City

Record History

  1. Notable Primary completion pushed from Jul 30, 2026 to Jul 30, 2028
    • Study completion pushed from Jul 31, 2026 to Jul 31, 2028
    • Site contact updated
    v5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  3. Notable Start date: May 13, 2025 to Jul 31, 2025
    • Primary completion date: Apr 30, 2026 to Jul 30, 2026
    v3
  4. Notable Start date: Mar 13, 2025 to May 13, 2025
    • Site contact updated
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Trial Details
NCT Number NCT06834594
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions
(from sponsor)
Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Related terms Primary Ovarian Insufficiency, Turner Syndrome
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov